Remove 2029 Remove Patient Care Remove Pharmaceutical Companies
article thumbnail

AI in Life Sciences: Exploring Innovation and Opportunities

Viseven

in 2029 , with a compound annual growth rate of 27.9%. In 2024 , the top 20 pharmaceutical companies have already announced that they are actively researching uses for AI in R&D. In life sciences, chatbots and virtual assistants can be used by pharmaceutical companies to improve communication with patients.

article thumbnail

Digitalisation of the clinical trial landscape

European Pharmaceutical Review

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. This approach facilitates a comprehensive understanding of medical information and enhances the management of patient care.